Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Alternatives and Vascular Function
NCT00108238Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postmenopause comparing Estradiol/Progesterone, Raloxifene and Placebo (3 arms). Primary endpoints: PET coronary flow reserve at 3 months and Brachial artery ultrasound at 3 months. Started Apr 2003; status: completed.
02
Drugs
raloxifeneestradiol
03
Conditions
postmenopause
Beyond the preview
Go deeper on NCT00108238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108238.